FDA 执法报告 D-0167-2027 将费森尤斯 DELFLEX 腹膜透析液召回列为 II 类
FDA drug enforcement D-0167-2027: Fresenius Medical Care Renal Therapies Group, LLC — Lack of Assurance of Sterility:complaints have been received related to potential leaks from small perforations in the print area on the primary bag in the affected lots.
FDA 执法报告 D-0167-2027 将 Fresenius Medical Care Renal Therapies Group 的 DELFLEX 腹膜透析液召回列为 II 类,原因为无菌保证不足。
记录列出受影响批号、有效期、包装规格与美国全国分销范围,便于核对具体批次及无菌保证不足的说明。
FDA drug recall enforcement report — D-0167-2027
Report issued: 2026-11-11. This is the enforcement report date, not the recall initiation date.
Scope: one classified drug product recall record; event_id may group multiple products. Unclassified records without recall numbers are outside this stream. This record is not a press release or a new enforcement finding.
The openFDA dataset is updated weekly. Report status is not a live recall status and must not be used to track the recall lifecycle. Other dates below retain their named meanings.
Complete official product record (including openFDA harmonized identifiers):
{
"address_1": "350 Merrimack St",
"address_2": "",
"center_classification_date": "20261103",
"city": "Lawrence",
"classification": "Class II",
"code_info": "Lot #: 25JGPD045, Lot 25JGPD046, Lot 25JGPD060, Exp 1/31/2027; 25KGPD057, Exp 2/28/2027.",
"country": "United States",
"distribution_pattern": "Nationwide in the USA.",
"event_id": "100130",
"initial_firm_notification": "Letter",
"more_code_info": "",
"openfda": {
"application_number": [
"NDA020171"
],
"brand_name": [
"DELFLEX"
],
"generic_name": [
"DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE"
],
"is_original_packager": [
true
],
"manufacturer_name": [
"Fresenius Medical Care de Mexico, S.A. de C.V."
],
"package_ndc": [
"46163-209-92",
"46163-209-94",
"46163-209-95",
"46163-212-95",
"46163-212-92",
"46163-212-94",
"46163-206-92",
"46163-206-94",
"46163-206-95"
],
"product_ndc": [
"46163-206",
"46163-209",
"46163-212"
],
"product_type": [
"HUMAN PRESCRIPTION DRUG"
],
"route": [
"INTRAPERITONEAL"
],
"spl_id": [
"5f14959c-adcd-923c-e063-6294a90ab6de"
],
"spl_set_id": [
"a98facd6-9daa-4d37-8209-63a0599dbfaa"
],
"substance_name": [
"DEXTROSE MONOHYDRATE",
"SODIUM CHLORIDE",
"SODIUM LACTATE",
"CALCIUM CHLORIDE",
"MAGNESIUM CHLORIDE"
],
"unii": [
"TU7HW0W0QT",
"LX22YL083G",
"02F3473H9O",
"451W47IQ8X",
"M4I0D6VV5M"
]
},
"postal_code": "01843-1748",
"product_description": "DELFLEX Peritoneal Dialysis Solution with 1.5% Dextrose, Low Magnesium/ Low Calcium and Attached stay safe Exchange Set, 2,000 mL - Single Dose Bag, Sterile and Non-Pyrogenic, Rx only, CAT.NO. 054-20221. Fresenius Medical Care, Renal Therapies Group, LLC, Lawrence, MA 01843. NDC 46163-206-92",
"product_quantity": "4,232 cases (5 bags per case)",
"product_type": "Drugs",
"reason_for_recall": "Lack of Assurance of Sterility:complaints have been received related to potential leaks from small perforations in the print area on the primary bag in the affected lots.",
"recall_initiation_date": "20261014",
"recall_number": "D-0167-2027",
"recalling_firm": "Fresenius Medical Care Renal Therapies Group, LLC",
"report_date": "20261111",
"state": "MA",
"status": "Ongoing",
"voluntary_mandated": "Voluntary: Firm initiated"
}
来源:openFDA 已分级药品召回执法报告 · api.fda.gov